Serum YKL-40 levels in rheumatoid arthritis: Correlations between clinical and laboratory parameters

Clinical and Experimental Rheumatology

Volumn 19, Issue 6, 2001, Pages 655-660

  Matsumoto, T ^a   Tsurumoto, T ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Cartilage; Cytokine; Rheumatoid arthritis; Serum marker; YKL 40

Indexed keywords

C REACTIVE PROTEIN; GLYCOPROTEIN GP 39; INTERLEUKIN 6; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION FUNCTION; DISABILITY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATION; JOINT DESTRUCTION; LABORATORY; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; PAIN ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOLOGY; RHEUMATOID ARTHRITIS; SCORING SYSTEM;

ADULT; AGED; ARTHRITIS, RHEUMATOID; ARTHROGRAPHY; AUTOANTIGENS; BIOLOGICAL MARKERS; FEMALE; GLYCOPROTEINS; GROWTH SUBSTANCES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-6; JOINTS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 0035661247     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. A new biochemical marker for joint injury. Analysis of YKL-40 in serum and synovial fluid
2. Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells is a mammalian member of chitinase protein family
3. Identification of proteins secreted by human osteoblastic cells in culture
4. Isolation and sequence of a novel human chondrocyte protein related to mammalian members of the chitinase protein family
5. Human synovial cells secrete a 39 kDa protein similar to a bovine mammary protein expressed during the non-lactating period
6. Induction and expression of human cartilage glycoprotein 39 in rheumatoid inflammatory and peripheral blood monocyte-derived macrophages
7. YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils
8. Human cartilage glycoprotein 39 (HC gp-39) mRNA expression in adult and fetal chondrocytes, osteoblasts and osteocytes by in-situ hybridization
9. A new biochemical marker for joint injury. Analysis of YKL-40 in serum and synovial fluid
10. Chondrex: New marker of joint disease
11. Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis
12. Serum YKL-40 concentrations in patients with rheumatoid arthritis: Relation to disease activity
13. Levels of circulating tumor necrosis factor α and interleukin-6 in patients with rheumatoid arthritis. Relationship to serum levels of hyaluronan and antigen keratan sulfate
14. Production of interleukin-6 by monocytes isolated from rheumatoid arthritis patients receiving second line drug therapy
15. Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor α, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy
16. Decrease of interleukin 6 during the first 12 months is a prognostic marker for clinical outcome during 36 months treatment with disease-modifying anti-rheumatic drugs
17. Insulin-like growth factor stimulation of chondrocyte proteoglycan synthesis by human synovial fluid
18. Human osteoarthritic chondrocytes possess an increased number of insulin-like growth factor-I binding sites but are unresponsive to its stimulation
19. Identification and characterization of insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and IGFBP proteases in human synovial fluid
20. Elevated levels of insulin-like growth factor (IGF) binding protein-3 in rheumatoid arthritis synovial fluid inhibit stimulation by IGF-I of articular chondrocyte proteoglycan synthesis
21. Multicenter study on insulin-like growth factor-I serum levels in children with chronic inflammatory diseases
22. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
23. Quantification of the manifestations of rheumatoid arthritis. 4. Area of joint surfaces as an index to total joint inflammation and deformity
24. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films
25. The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis
26. Methods of scoring the progression of radiologic changes in rheumatoid arthritis
27. Purification of Guinea pig YKL40 and modulation of its secretion by cultured articular chondrocytes
28. Serum YKL-40 levels in healthy children and adults, comparison with serum and synovial fluid levels of YKL-40 in patients with oateoarthritis or trauma of the knee joint
29. The relationship between serum levels of YKL-40 and disease progression in patients with early rheumatoid arthritis
30. The distribution of YKL-40 in osteoarthritic and normal human articular cartilage
31. Concentration and localization of YKL-40 in hip joint diseases
32. Induction of tolerance with intranasal administration of human cartilage gp-39 in DBA/1 mice. Amelioration of clinical, histologic, and radiologic signs of type II collagen-induced arthritis